Sobre 1 señal de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Discover the detailed record of transactions filed by Coughlin Timothy, Consejero. Insider active across 5 companies, notably Travere Therapeutics, Inc.. Aggregated, 20 disclosures have been logged. Breakdown: 1 buy · 2 sells. Total volume traded: €111k. History available since 14 May 2021. The latest transaction was filed on 1 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Coughlin Timothy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
COUGHLIN TIMOTHY is Administrateur and has been associated with Travere Therapeutics, Inc., ADC Therapeutics SA, aTYR PHARMA INC, Fate Therapeutics INC and Vir Biotechnology, Inc. The declarant has 20 filings in total, and within the sampled recent filings the period runs from 2021-05-18 to 2026-06-16, with buy volume of EUR 80754 and sell volume of EUR 30531, and the modal transaction nature is Attribution.